Industry News
Overlooked cytokine potential anticancer agent
Interleukin-11 has revealed itself to be a potential new target for anticancer therapies. [ + ]
Deadline extended for The Australian Innovation Challenge
On 8 July, entries in this year’s $70,000 The Australian Innovation Challenge awards were officially opened. The deadline was originally 26 August but it has now been extended until 9 September. [ + ]
MDI achieves goals with Penthrox trial
Medical Developments International (ASX:MVP) said a safety study of its Penthrox inhaler uncovered no safety concerns associated with a single supratherapeutic dose. [ + ]
Viralytics to get wider EU oncolytic virus patent
Viralytics (ASX:VLA) will be granted a European patent covering a wider group of oncolytic viruses that bind to ICAM-1, target of the company’s Cavatak candidate. [ + ]
Compumedics expects return to black for 1H14
Compumedics (ASX:CMP) expects to report a loss for FY13, but is projecting a return to profitability in 1H14 as it resolves its order-backlog issues. [ + ]
Ita Buttrose to speak on philanthropy for research
Legendary media editor, businesswoman and 2013 Australian of the Year Ita Buttrose will be the guest dinner speaker at next week’s Research Australia 2013 Philanthropy for Health and Medical Research conference. [ + ]
Register to attend ComBio2013
ComBio 2013 will be held from 29 September to 3 October 2013 at the Perth Convention Centre. The program will feature 17 plenary presentations from highly regarded international scientists, plus six society speciality lectures. [ + ]
UNSW responds to the ABC’s claim that its research into DZ13 was flawed
The University of New South Wales responds to claims that the research into the antiskin cancer drug, DZ13, was flawed. Clinical trials have been suspended as a third round of investigations continue. [ + ]
Nominations open for 2013 NSW Science and Engineering Awards
Scientists, engineers, researchers and teachers are now encouraged to submit nominations for the NSW Science and Engineering Awards. [ + ]
Research into precision agriculture recognised
The 2014 winner of what is widely regarded as the Nobel prize for soil science, the Dokuchaev award, is an Australian researcher. [ + ]
Cochlear FY13 profit recovers after recall
Cochlear Limited (ASX:COH) reported a net profit for FY13 of $132.6m - up 133% year on year, but down 16% when excluding the costs of a product recall in FY12. [ + ]
Nexvet appoints VP of operations
IP law expert Geraldine Farrell will join Melbourne-based Nexvet as the company’s VP of operations and general counsel. [ + ]
Viralytics commences trading on OTCQX
Viralytics (ASX:VLA) ADRs are now being traded on the US-based OTCQX International marketplace. [ + ]
Endangered species choke on plastic
When a plastic bag floats in the ocean it looks like a jellyfish, especially to a hungry turtle swimming by. [ + ]
Get ready to book for CERN’s open day
From 9.00 am to 8.00 pm on 28 and 29 September, sightseers will have the chance to explore the laboratories, technical halls, experiments and accelerators at the biggest particle physics centre in the world - CERN. [ + ]
